Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1172020060070010101
Journal of Korean Bioethics Association
2006 Volume.7 No. 1 p.101 ~ p.116
Regulations and Policies on Research Misconduct :With special reference to the Office of Research Integrity in the United States
Lee June-Seok

Kim Ock-Joo
Abstract
This paper examines regulations and policies on research misconduct, focusing on the Office of Research Integrity (ORI) under Department of Health and Human Service (DHHS) USA. After decades of dealing with research misconduct, U.S. DHHS established the ORI as a governmental branch office to oversee research integrity in biomedical researches supported by the U.S. Public Health Services (PHS). The ORI set a formal procedure when a research misconduct has been reported by a whistleblower, and also provides standard procedures to investigate misconduct at the research institutional level. Such transparent system for handling misconduct as ORI system promote accountable conduct of research. By reviewing three notable cases of scientific misconduct in the United States (Jan Hendrik Schoen¡®s case in 2002, Xiaowu Li¡¯s and Eric T. Poehlman¡¯s case in 2005), the authors how ORI deals with research misconduct. Even before Hwang¡¯s scandal, Korean society had experienced a series of research misconduct allegations, even if their scale was not as big as Hwang¡¯s. Finally, analyzing Dr. Hwang Woo-Suk¡¯s case as a call for building a system to prevent research misconduct, the authors maintain that ORI-like institutions are urgently needed in Korea.
KEYWORD
research integrity, Office of Research Integrity (ORI), research ethics, research misconduct, Hwang Woo-Suk
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)